Omada Health (NASDAQ:OMDA) CEO Sean Duffy Sells 12,944 Shares of Stock

Omada Health, Inc. (NASDAQ:OMDA) CEO Sean Duffy sold 12,944 shares of Omada Health stock in a transaction that occurred on Monday, August 3rd. The stock was sold at an average price of $20.40, for a total transaction of $264,057.60. Following the completion of the transaction, the chief executive officer directly owned 411,861 shares in the company, valued at approximately $8,401,964.40. This trade represents a 3.05% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Omada Health Price Performance

OMDA stock opened at $19.11 on Thursday. The firm has a market capitalization of $1.14 billion, a P/E ratio of -70.78 and a beta of 1.73. Omada Health, Inc. has a 52-week low of $10.28 and a 52-week high of $26.92. The company’s 50 day simple moving average is $20.21 and its 200-day simple moving average is $16.12.

Omada Health (NASDAQ:OMDA) last posted its quarterly earnings data on Thursday, May 7th. The company reported ($0.05) EPS for the quarter, topping analysts’ consensus estimates of ($0.08) by $0.03. Omada Health had a negative net margin of 2.22% and a negative return on equity of 1.82%. The firm had revenue of $78.05 million during the quarter. Sell-side analysts predict that Omada Health, Inc. will post -0.01 EPS for the current fiscal year.

Institutional Investors Weigh In On Omada Health

A number of institutional investors have recently modified their holdings of the stock. Raymond James Financial Inc. acquired a new position in shares of Omada Health in the second quarter worth $32,000. Bellevue Group AG raised its holdings in shares of Omada Health by 0.7% during the third quarter. Bellevue Group AG now owns 251,791 shares of the company’s stock worth $5,567,000 after acquiring an additional 1,791 shares in the last quarter. Quarry LP acquired a new stake in Omada Health during the fourth quarter valued at $29,000. Barclays PLC grew its stake in Omada Health by 14.6% in the fourth quarter. Barclays PLC now owns 14,850 shares of the company’s stock valued at $234,000 after purchasing an additional 1,888 shares in the last quarter. Finally, TD Waterhouse Canada Inc. purchased a new position in Omada Health in the fourth quarter valued at about $32,000.

Analysts Set New Price Targets

Several analysts have recently commented on the company. Weiss Ratings cut Omada Health from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Monday, July 13th. BTIG Research began coverage on Omada Health in a research report on Friday, July 17th. They set a “buy” rating and a $30.00 price target on the stock. Evercore reissued an “outperform” rating and issued a $20.00 price objective on shares of Omada Health in a research note on Friday, May 8th. Citigroup restated an “outperform” rating on shares of Omada Health in a research report on Monday, July 20th. Finally, Citizens Jmp lifted their target price on Omada Health from $21.00 to $27.00 and gave the company a “market outperform” rating in a research note on Monday, July 20th. Eleven investment analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $24.75.

About Omada Health

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.